title: Muscle glutamine depletion in the intensive care unit.
abstract: Glutamine is primarily synthesized in skeletal muscle and enables transfer of nitrogen to splanchnic tissues, kidneys and immune system. Discrepancy between increasing rates of glutamine utilization at whole body level and relative impairment of de novo synthesis in skeletal muscle leads to systemic glutamine deficiency and characterizes critical illness. Glutamine depletion at whole body level may contribute to gut, liver and immune system disfunctions, whereas its intramuscular deficiency may directly contribute to lean body mass loss. Severe intramuscular glutamine depletion also develops because of outward transport system upregulation, which is not counteracted by increased de novo synthesis. The negative impact of systemic glutamine depletion on critically ill patients is suggested both by the association between a lower plasma glutamine concentration and poor outcome and by a clear clinical benefit after glutamine supplementation. Enteral glutamine administration preferentially increases glutamine disposal in splanchnic tissues, whereas parenteral supplementation provides glutamine to the whole organism. Nonetheless, systemic administration was ineffective in preventing muscle depletion, due to a relative inability of skeletal muscle to seize glutamine from the bloodstream. Intramuscular glutamine depletion could be potentially counteracted by promoting de novo glutamine synthesis with pharmacological or nutritional interventions.
authors.affiliation: Department of Clinical, Morphological and Technological Sciences, University of Trieste, Trieste, Italy. biolo@units.it
authors.forename: Gianni
authors.initials: G
authors.lastname: Biolo
authors.forename: Francesca
authors.initials: F
authors.lastname: Zorat
authors.forename: Raffaella
authors.initials: R
authors.lastname: Antonione
authors.forename: Beniamino
authors.initials: B
authors.lastname: Ciocchi
mesh_terms: D001692:Biological Transport; D016638:Critical Illness / Q000628:therapy*; D019587:Dietary Supplements; D005973:Glutamine / Q000008:administration & dosage / Q000096:biosynthesis / Q000172:deficiency*; D006801:Humans; D007263:Infusions, Parenteral; D007362:Intensive Care Units; D008954:Models, Biological; D018482:Muscle, Skeletal / Q000378:metabolism*
chemical_list: D005973:Glutamine